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Abstract
Background: It is unclear how the public would respond to changes in government decisions about how much to
spend on medical research in total and specifically on major disease areas such as cancer. Our aim was to elicit the
views of the general public in the United Kingdom about how a change in government spending on cancer
research might affect their willingness to donate, or to hypothecate a portion of their income tax payments, to
cancer research charities.
Methods: A web-based stated preference survey was conducted in 2013. Respondents considered hypothetical
scenarios regarding changes in the levels of government funding for medical research. In each scenario,
respondents were asked to imagine that they could allocate £100 of the income tax they paid this year to one or
more medical research charities. They were asked how they wished to allocate the £100 between cancer research
charities and medical research charities concerned with diseases other than cancer. After having been given the
opportunity to allocate £100 in this way, respondents were then asked if they would want to reduce or increase
any personal out-of-pocket donations that they already make to cancer research and non-cancer medical research
charities. Descriptive analyses and random effects modelling were used to examine patterns in the response data.
Results: The general tendency of respondents was to act to offset hypothetical changes in government spending.
When asked to imagine that the government had reduced (or increased) its spending on cancer research, the
general tendency of respondents was to state that they would give a larger (or smaller) allocation of their income
tax to cancer research charities, and to increase (or reduce) their personal out-of-pocket donations to cancer
research charities. However, most respondents’ preferred allocation splits and changes in personal donations did
not vary much from scenario to scenario. Many of the differences between scenarios were small and non-
significant.
Conclusions: The public’s decisions about how much to donate to cancer research or other medical research
charities are not greatly affected by (hypothetical) changes to government plans about the amount of public
funding of cancer or other medical research.
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Background
Investment in medical research contributes to the continu-
ing improvement of human health and wealth. Medical
research is funded from three sources: government alloca-
tion of tax funds, medical research charities disbursing
donors’ funds, and private industry investing for commer-
cial gain. There is a substantial literature on the relation-
ship, generally determined to be one of complementarity,
between government and private industry funding of
medical research (much of that literature has been
previously summarised [1]). There is, however, little
evidence about the relationship between government
and charity funding of medical research.
The United Kingdom has a large number of medical
research charities, some of which have very large funds at
their disposal. Overall, charity funding of medical research
tops £1 billion annuallya [2] and compares with United
Kingdom government funding of medical research, which
is around £2.5 billion annually [3]. The deep economic
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recession that hit many economies in 2008 and the follow-
ing years have led many governments, including the United
Kingdom government, to undertake fundamental reviews
of all public expenditure, including public funding of re-
search. The question therefore arises whether a cut in
public funding of medical research might prompt any
offsetting increased donations by the public to medical
research charities, or not, or whether it might even lead to
the public being less willing to donate to medical research.
We set out to determine whether and how government
decisions to allocate tax funds to different areas of medical
research affect the general public’s desire in the United
Kingdom to fund those areas of medical research. Does
government funding crowd out the general public’s will-
ingness to fund a particular area of medical research or
does it act to attract more funds from the general public,
or does it have no effect either way? If the public were per-
mitted to hypothecate a small part of their annual income
tax payment to medical research charities (as is possible in
Italy), how would they react to changed government prior-
ities for funding medical research?
Brief overview of literature
There are theoretical arguments supporting both “crowd-
ing out” effects, i.e. decreases in government funding of
research lead to donors increasing their own contributions
[4-8], and “crowding in” effects, i.e. decreases in govern-
ment funding lead to donors reducing their own contribu-
tions [9,10]. The former may be driven by altruistic
motivation: donors increase their own contributions as
they learn about reductions in contributions by others.
The latter may be driven by a type of signalling effect
whereby government spending decisions act as a signal to
donors who lack information about societal priorities [11].
The literature typically presents signalling models of char-
itable giving in the context of donors facing uncertainty
regarding the quality of a beneficiary charity: government
funding of a charity is seen as a signal of the quality of that
particular organisation rather than of the cause the charity
is supporting. Government funding of charities is less
common in the United Kingdom than the United States,
and our study concerns the impact on funding of the char-
itable cause, medical research, rather than of any particu-
lar charity organisation. However, a similar signalling
concept may apply if donors face uncertainty about the
comparative worthiness of competing charitable causes.
Alternatively, decisions about whether and how much
to donate may be driven by positive psychological
consequences for the donor, often labelled “warm
glow” or “joy of giving” effects [12]. A number of
studies have tested the crowding out and crowding in
hypotheses by examining panel data (e.g. [8,10,11,13-
18]). Eckel et al. [19], Crumpler and Grossman [20],
and Li et al. [21] adopted a different approach, using
laboratory experiments to test the same or related
hypotheses.
The majority of published studies report United States
data and may not translate to other nations. With their
United States focus, most of the studies examine the impact
of direct government grants to charities themselves but
such grant funding is uncommon in some other countries,
including the United Kingdom.
There are very few studies that specifically examine
funding for research, let alone science or medical research
specifically. A notable exception is Diamond [16], who
reports that United States donors view federal and private
spending on basic research as complements and suggests
that “private funding could not be expected to replace lost
federal funding of science”. Furthermore, most of the
studies focus on increases in government spending,
whereas, given the economic climate since 2008, it
would be more appropriate to consider the impact of
cuts in real terms government spending.
We are not aware of any studies that have used stated
preference methods to examine the complementarity or
substitutability of government funding and private dona-
tions for medical research. Stated preference studies are
increasingly being used in the field of health, particularly to
examine public preferences regarding health care priority
setting [22]. A stated preference approach was also used
successfully in a recent study examining the effects of
different forms of tax relief on charitable giving [23].
Although surveys comprising hypothetical questions have
disadvantages, they are particularly useful when informa-
tion about revealed preferences (i.e. data from observed
behaviour) is unavailable – in this case, when seeking to
understand the potential impact of a cut in government
spending that has not yet occurred.
Objectives of the study
The aim of our study was to elicit, using a stated prefer-
ence method, the views of the general public in the United
Kingdom about how a change in government spending on
cancer research might affect people’s willingness to donate
to cancer research charities and to hypothecate tax reve-
nues to different areas of medical research. The latter idea
is similar to the situation in Italy, where, since 2006,
taxpayers have been offered the opportunity to donate
0.5% of the income tax they pay to non-profit organisa-
tions of their choosing [24]. We also sought to address the
lack in the existing literature on charitable behaviour of
studies that focus on medical research and charitable giv-
ing outside the United States.
We focused on cancer as a high profile disease area,
research into which attracts substantial government and
charity funding in the United Kingdom (not least by the
grant funder of this research study: Cancer Research UK).
Due to the identity of the funder of this study – which we
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declared to respondents up-front – we were concerned
that the survey should not appear as a veiled request for
donations. The “cinque per mille” income tax hypotheca-
tion policy current in Italy, referred to above, suggested a
framework that would enable interesting questions to be
asked about individuals’ preferences for their own taxes to
be spent on different areas of medical research.
The stated preference survey was designed to answer
the following key research questions:
1. If given the opportunity to allocate some of the
income tax they pay this year to one or more
medical research charities, how would people
choose to distribute that amount between cancer
research and other medical research charities?
2. Would being given the opportunity to allocate some
of their income tax to cancer and other medical
research charities lead people to change their
existing personal out-of-pocket donations to those
types of charities?
3. Would people’s preferred allocations of funds change
if they were to learn that the government was




The survey began with some preliminary questions. First,
respondents were presented with a list of well-known
cancer research charities and were asked to indicate which
of those charities, if any, they had given money to in the
past year. An “Other” option was included to allow respon-
dents to specify the name of a cancer research charity that
they had given money to that was not included in the list.
Respondents were then asked a similar question but about
medical research charities focusing on diseases other than
cancer (for example, the British Heart Foundation).
Second, respondents were asked to guess: (1) how much
the United Kingdom government currently spends on
medical research each year, in millions of pounds; and (2)
the percentage of total United Kingdom government
spending on medical research each year that is on cancer
research. It was assumed that respondents would not know
the answers to either of these questions, but we sought
information on their best guesses to help us interpret their
responses to later questions.
Third, respondents were asked to indicate whether they
thought that United Kingdom government funding of
medical research had been going up or down, or had
remained about the same, over the last 3 years. They were
then asked the same question, but focusing specifically on
cancer research.
The main part of the survey comprised five hypothetical
scenarios. In each scenario, respondents were asked to
imagine that they had the opportunity to allocate £100 of
the income tax they paid this year to one or more medical
research charities. We focused on a sum of £100 as being
large enough for respondents to care about how it would
be spent, but small enough to be plausible (it equates to
1.8% of the average income tax payment), and to make it
easy for respondents so-inclined to think in percentage
terms when allocating the money. Respondents were asked
how they wished to allocate the £100 between cancer re-
search charities and medical research charities concerned
with diseases other than cancer. The recipients of the allo-
cation would be unnamed charities of the respondents’
choosing. An alternative approach would have been to ask
respondents to allocate the £100 between individual, named
charities. We opted against this for two reasons: first, be-
cause we wished to examine the interdependency, if any,
between government and charity funding of medical re-
search, not the status of different medical research charity
organisations; and second, because the name of the charity
funding the study had been made explicit, so asking re-
spondents whether they would give to that particular char-
ity might have led to biased responses.
After having been given the opportunity to allocate £100
in this way, respondents were then asked if they would
want to reduce or increase any personal donations that
they already make out of their own pocket to cancer re-
search and non-cancer medical research charities and, if
so, by how much. Respondents were only asked about
changes to their out-of-pocket personal donations if they
had earlier claimed to have made financial donations to
medical research charities in the previous year (see above).
These questions allowed us to test the extent to which
having the opportunity to allocate some of their income
tax to medical research charities might affect people’s will-
ingness to donate from their own (post-tax) resources.
Table 1 summarises the information provided to respon-
dents in the five scenarios.
In scenario 1, no information was provided about
research funding levels. In scenario 2, respondents were
presented with rounded estimates of how much the
government and charities actually spend on medical
research in the United Kingdom each year (figures based
on previous data [3,25]). The actual levels of spending on
medical research may be very different from what respon-
dents would have been expecting. Comparing scenarios 1
and 2 allows us to test whether respondents revise their
choices of allocations when they become better informed
about research funding levels.
In scenario 3, respondents were asked to imagine a
hypothetical situation where the government has reduced
its annual spending on cancer research from £150 million
(as in scenario 2) to £50 million, and has spent the £100
million difference on more research into diseases other
than cancer. The crowding out hypothesis suggests that
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respondents would seek to make up the gap by increasing
the amount they give to cancer research charities. Alterna-
tively, respondents may view the government’s decision to
redirect resources away from cancer research towards
other areas of medical research as a signal that cancer re-
search is a relatively low priority for society (hence com-
paring scenarios 2 and 3 allows us to test the signalling
hypothesis). If so, they may follow suit by reducing the
amount they give to cancer research charities.
Scenario 4 replicates scenario 3, except that the
government does not increase its spending on other
areas of medical research, so total annual government
spending on medical research has been reduced by the
same £100 million that has been cut from spending on
cancer research.
Finally, in scenario 5, the government has increased its
annual spending on cancer research by £100 million and
has found that money by reducing its spending on research
into diseases other than cancer by £100 million. It was
hypothesised that, if a respondent reacts to hearing that the
government has reduced its spending on cancer research
by increasing (or reducing) the share of the £100 allocation
they give to cancer research charities, then they may react
to hearing the government has increased its spending on
cancer research by reducing (or increasing) the share for
cancer research charities.
Information about the levels of funding for research
from charities remained constant throughout the sce-
narios, and was included to provide some context to
the respondents. Once the respondents had completed
the questions relating to the five scenarios, they were
invited to provide comments to support their answers.
Respondents who had claimed not to have given
money to any cancer research charities in the previous
year were asked what, if anything, might encourage
them to donate to a cancer research charity.
The next question sought to elicit respondents’
views more directly, asking them whether hearing that
the government has reduced its spending on cancer
research would make them more or less likely to do-
nate to a cancer research charity, or to donate more or
less than they already do. Alternatively, respondents
could indicate that government spending decisions
make no difference to their donation decisions.
Finally, the respondents were asked some background
questions about the types of charity donations they had
made in the last year (to any kind of charity, medical or
otherwise); whether the level of their charity donations
had been going up, going down, or remained about the
same; and whether they had any personal experience of
cancer.
Administration of survey
The questions were included in a self-completion web-
based survey. The survey was administered on a sample of
adult members of the United Kingdom general public, all
of whom were members of a panel managed by Aurora
MR, a market research agency. We sought a sample that
was representative of the general population in terms of
age and sex. We also sought respondents from different
socioeconomic grades, choosing to oversample those from
the very highest grades (A and B) in order to obtain a
large subsample comprising individuals who might be ex-
pected a priori to be more likely than average to be regu-
lar givers of large charity donations (or to become such
givers in the future). Screen-in questions, combined with
a “minimum quota” approach, were used to ensure that
the sample comprised individuals with the appropriate
characteristics. Respondents were compensated for taking
part by way of “reward points” which can be redeemed for
gift vouchers.
Table 1 Summary of scenarios used in the survey
Scenario Amount spent on medical research in the United













1 No information provided to respondent Scenario included to capture respondents’ preferences in the absence of
information about medical research funding levels
2 150 2,350 350 650 Realistic estimates of actual spending on medical research
3 50 2,450 350 650 Government reduces its spending on cancer research and spends that money
instead on other medical research
4 50 2,350 350 650 Government reduces its spending on cancer research; spending on other
medical research remains unchanged
5 250 2,250 350 650 Government increases its spending on cancer research and reduces its
spending on other medical research by the same amount
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Information about the scenarios was presented using a
combination of text descriptions and diagrams (see Figure 1
for an example screenshot). All responses were recorded
via the web-based survey. In order to control for potential
ordering effects, the respondents were randomly assigned
to one of two blocks that determined the order in which
the scenarios were presented to them. Respondents in the
first block faced the scenarios in the same order as de-
scribed above (12345); respondents in the second block
were presented with the scenario describing an increase in
the government’s funding for cancer research before
proceeding to the scenarios describing reductions in the
government’s funding for cancer research (12534).
The study design was informed by a focus group, which
was used to pilot a draft paper version of the survey and
to seek feedback from general public participants. The
design of the draft survey had itself been informed by
feedback on several alternative designs received from two
experts in stated preferences and hypothetical survey
design. The focus group took place in London in May
2013. Nine members of the general public took part, all of
whom claimed to support the principle of giving to
charity.
The comments received were largely favourable, with
participants describing the scenarios as interesting and
easy to understand, and claiming that the survey was
straightforward to complete without assistance. However,
the participants also criticised the survey for being overly
“wordy” and repetitive, and some participants questioned
the plausibility of some of the scenarios.
The findings from the focus group informed the design
of the final survey in a number of ways, in particular,
reduced repetition from scenario to scenario; the use of dia-
grams (rather than tables) to demonstrate the key pieces of
information in the scenarios; and the use of features to
make the web-based survey more user-friendly than its
pen-and-paper counterpart. We also made the reference to
the Italian tax hypothecation policy more prominent, as
participants felt that knowing this made the hypothetical
scenarios seem more realistic.
Ethics
Ethical review was not required for this study, in accord-
ance with the National Health Service National Research
Ethics Service algorithm for determining whether review
by an National Health Service Research Ethics Committee
is required [26].
Results
Overview of the sample
The survey was carried out in the United Kingdom in July
2013. Respondents who completed the survey in less than
3.5 minutes were excluded from the sample due to con-
cerns about data quality (n = 74), leaving a sample of 401
respondents. Table 2 presents the background characteris-
tics of the sample. By design, the sample was broadly rep-
resentative of the general United Kingdom population
with respect to age and sex [27], and comprised a larger
proportion of individuals in the highest socioeconomic
grades [28].
Respondents’ guesses about government spending levels
Figure 2 shows the distribution of answers given by respon-
dents when asked: (1) how much the United Kingdom
Figure 1 Screenshot from web-based survey (scenario 3).
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government spends on medical research each year, in
millions of pounds (vertical axis) and (2) what propor-
tion of the total United Kingdom government spend-
ing on medical research each year is spent on cancer
research (horizontal axis). The vast majority (96.3%) of
respondents underestimated total government spend-
ing on medical research (median guess = £24 million;
actual figure approx. £2,500 million), and a similarly
large majority overestimated the proportion of govern-
ment spending on medical research that is spent on
cancer research (median guess approx. 30%; actual
figure approx. 6%; actual figures based on [3,25]). The
majority of respondents guessed that government
funding of cancer research had either been going down
(33.7%) or remained about the same (35.2%) over the past
3 years, with most of the remainder selecting the “don’t
know” option.
Responses to the scenario questions
Table 3 reports the aggregate response data for the five
scenarios. In scenario 1, in which no information about
actual levels of medical research funding was provided,
the respondents were fairly equally split between giving
the majority of the £100 allocation of their income tax
payment to cancer research charities (38.2%), giving the
majority to non-cancer medical research charities (27.9%),











60 and over 123 30.7
Social grade (refers to the occupation/responsibilities of the chief wage earner of the respondent’s household)
A (higher managerial, administrative, or professional) 23 5.7
B (intermediate managerial, administrative, or professional) 144 35.9
C1 (supervisory or clerical and junior managerial, administrative, or professional) 95 23.7
C2 (skilled manual workers) 52 13.0
D (semi-skilled and unskilled manual workers) 27 6.7
E (state pensioners, casual and lowest grade workers, unemployed with state benefits only) 60 15.0
Types of charity donations made in the last year
Money – regular donation 127 31.7
Money – one-off donation 241 60.1
Money – other (charity events, auctions, etc.) 126 31.4
Non-financial (donation of unwanted goods, volunteering, etc.) 223 55.6
None of the above 45 11.2
Over the last 3 years, what has happened to the level of your charity donations(s)?
Gone up 66 16.5
Gone down 56 14.0
About the same 279 69.6
Personal experience of cancer (respondents could tick multiple boxes)
Yes, self 34 8.5
Yes, close friend or relative 275 68.6
No 87 21.7
No answer given 22 5.5
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and splitting the allocation equally between cancer
research and non-cancer medical research charities
(33.9%). In all of the subsequent scenarios, the pro-
portion of respondents giving the majority of the allo-
cation to cancer research charities was greater than in
scenario 1. Respondents were most likely to give the
majority of the allocation to cancer research charities
in scenarios 3 and 4, when they were asked to im-
agine that the government had reduced its spending
on cancer research. One hundred and fifty-three re-
spondents (38.2%) opted for the same split between
cancer research and other medical research charities
in all five scenarios, including 48 respondents (12.0%)
who chose a 50:50 split on every occasion.
Figure 2 Distribution of guesses of levels of government spending.
Table 3 Aggregate response data for scenarios 1 to 5
Scenario









↑ Cancer research; ↓ other
medical research
Allocation to cancer research charities (out of notional £100 tax deducted sum)
<£50 27.9% 27.9% 26.9% 25.7% 29.4%
£50 33.9% 22.2% 16.5% 19.7% 25.4%
>£50 38.2% 49.9% 56.6% 54.6% 45.1%
Mean allocation to cancer research charities £53.60 £58.19 £63.15 £62.35 £56.47
Change in personal out-of-pocket donations to cancer research charitiesa
Would reduce 4.0% 1.8% 2.6% 2.2% 5.8%
Would increase 4.7% 9.1% 11.7% 9.5% 5.1%
Would not change 91.2% 89.1% 85.8% 88.3% 89.1%




+£1.12 +£1.54 +£1.51 –£0.21
Change in personal out-of-pocket donations to other medical research charitiesc
Would reduce 5.4% 8.3% 7.8% 5.4% 4.4%
Would increase 2.5% 2.0% 3.9% 3.9% 5.4%
Would not change 92.2% 89.7% 88.2% 90.7% 90.2%
Mean change in personal out-of-pocket donations to
other medical research charities
–
£0.52
–£0.78 –£0.37 +£0.09 +£0.02
aQuestions asked only to respondents who had given money to one or more cancer research charities in the previous year
bExcludes outlier (individual who claimed that they would increase their personal donations by £250)
cQuestions asked only to respondents who had given money to one or more non-cancer medical research charities in the previous year.
↓ denotes a reduction in government spending
↑ denotes an increase in government spending
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On average, from the £100 of income tax they were able
to allocate to medical research, respondents chose to give
£58.19 to cancer research charities and £41.81 to other
medical research charities in scenario 2, in which they were
presented with realistic estimates of government spending
levels. In the scenarios in which the government had
reduced its spending on cancer research, the average
amount from within the £100 of income tax to be allocated
to medical research that would be given to cancer research
charities increased by £4.96 and £4.16 (scenarios 3 and 4,
respectively). In the scenario in which the government had
increased its spending on cancer research, the average
amount given to cancer research charities from within the
£100 of income tax to be allocated fell by £1.72 per person,
on average (scenario 5). The mean allocation to cancer
research charities in scenario 2 is statistically significantly
smaller than the corresponding mean allocations in scenar-
ios 3 (t-test; P <0.01) and 4 (P <0.05). However, it is not
statistically significantly greater than the corresponding
mean allocation in scenario 5 (P >0.05).
In all five scenarios, of the respondents who had earlier
claimed to have given money to medical research charities
in the previous year, the vast majority (ranging from 88.2%
scenario 3 to 92.2% in scenario 1) said that they would not
change the level of their personal out-of-pocket charity
donations even after being given the opportunity to give
an extra £100 out of their income tax. These respondents
were most likely to increase their out-of-pocket donations
to cancer research charities in scenarios 3 and 4, when
they were asked to assume that the government had re-
duced its spending on cancer research; and were most
likely to increase their out-of-pocket donations to non-
cancer medical research charities in scenario 5, when they
were asked to assume that the government had increased
its spending on cancer research and had found that money
by reducing its spending on research into diseases other
than cancer.
Overall, 274 out of the 401 respondents (68.3%) said
that they had donated to cancer research charities in the
last year. Among that group of respondents, Table 3 shows
that the mean personal out-of-pocket donation to cancer
research charities would be greater in scenario 4 than in
scenario 2, but by just £0.39 per existing donor. We do not
observe a statistically significant difference in the mean
change in personal out-of-pocket donations when compar-
ing scenario 2 with scenarios 3, 4, or 5 (t-test; P >0.05 in all
three cases). However, the mean change in personal out-
of-pocket donation is statistically significantly smaller in
scenario 5 than in scenario 3 (P <0.05).
Figure 3 shows the distributions of the allocations given
to cancer research charities in each of the five scenarios.
The tendency to choose an even split between cancer
research and other medical research charities is greatest in
scenario 1. After being provided with information about
the levels of government spending on medical research
(scenarios 2 to 5), some respondents switch to giving the
entire allocation to cancer research charities. This ten-
dency is strongest in the scenarios that describe cuts in
government spending on cancer research. It is notable
that the distributions for scenarios 2 and 5 are near-
identical.
Across all scenarios, respondents with personal experi-
ence of cancer were less likely to choose even splits than
those without personal experience of cancer. The associ-
ation between having personal experience of cancer and
the propensity to choose an even split is statistically signifi-
cant (χ2 test; P <0.01). Respondents with personal experi-
ence of cancer gave larger allocations to cancer research
charities on average – the difference in mean allocations
between the experience/no experience groups was statisti-
cally significant (t-test; P <0.01). The differences in the dis-
tributions of the allocations between these groups were
statistically significant in scenarios 3 and 4 (Kolmogorov-
Smirnov test), where respondents with personal experience
of cancer were more likely than those without personal
experience of cancer to give a larger share of the allocation
to cancer research. No statistically significant differences
were found between the allocations of respondents in the
highest socioeconomic grades and those of respondents in
the lower grades.
Figure 4 shows the extent to which respondents chan-
ged their allocation choices from one scenario to another
(for selected pairs of scenarios). Compared to scenario 2
(the scenario presenting realistic government spending
estimates), respondents were more likely to give an in-
creased share of the allocation to cancer research charities
in scenarios 3 and 4 (the scenarios describing cuts to gov-
ernment funding for cancer research), and were slightly
more likely to give a reduced share in scenario 5 (the sce-
nario describing an increase in government funding for
cancer research).
Comparisons of respondents’ preferred allocations of
the £100 of their income tax with their subsequent stated
changes in personal out-of-pocket donations to cancer
and non-cancer medical research charities indicated the
following: the larger a respondent’s allocation to cancer
research charities, the more likely that respondent is to
increase (or reduce) their personal out-of-pocket dona-
tions to cancer research (or non-cancer medical research)
charities as a result of being given the opportunity to allo-
cate some of their income tax. The relationship between
respondents’ preferred allocations and the changes in their
personal donations to cancer research charities appears to
be strongest in scenarios 3 and 4.
In order to identify the drivers of choices whilst taking
into account clustering at the respondent level, we used the
STATA 13.1 software to estimate a random effects model
using a maximum-likelihood estimator. This model takes
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account of the fact that multiple responses are obtained
from the same individual and could be correlated. The
dependent variable corresponded to the allocation given to
cancer research charities. The statistical significance of a
number of independent variables was tested. These covered
background characteristics (e.g. sex, prior donations in the
last year), the order in which the scenarios were presented
(scenario 5 prior to scenarios 3 and 4, or vice versa), dum-
mies for each scenario or “treatment effect” (with scenario
1 assigned as the base scenario), and selected interactions
(e.g. order of the scenarios interacted with treatment
effects).
Model performance was assessed by examining the
Akaike and Bayesian information criteria; the base model
included only the dummies for each scenario. This model
was compared with a group of models that each included
the scenario dummies plus one of the independent vari-
ables. The model with the lowest Akaike and Bayesian
Figure 3 Distributions of the allocations given to cancer research charities.
Figure 4 Changes in allocations from one scenario to another (for selected pairs of scenarios).
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information criteria was selected. This was in turn com-
pared with a group of models that added a further inde-
pendent variable out of those remaining. The process was
repeated until adding further independent variables did not
improve Akaike and Bayesian information criteria. The re-
sults of the best-fitting model are shown in Table 4.
The coefficients for the dummies for scenarios 2 to
5 (in relation to scenario 1) were all positive and statisti-
cally significant. The dummy for respondents’ personal ex-
perience of cancer was also positive and statistically
significant, which indicates that respondents with personal
experience of cancer were more likely to give larger alloca-
tions to cancer research charities than those without that
experience. However, none of the coefficients for the
interactions between personal experience and the scenario
dummies were statistically significant, which suggests that,
although personal experience was a driver of respondents’
overall allocation choices, it did not affect the way in
which their allocation choices were influenced by informa-
tion about government spending decisions in the various
scenarios. The order in which the scenarios were presented
was not found to affect respondents’ overall allocations.
We used the Wald test and pairwise comparisons of
marginal predictions to compare the overall allocations
for all combinations of scenarios. We found that the dif-
ferences between scenarios were statistically significant at
the 5% level in all cases with the exception of the differ-
ence between scenarios 3 and 4 (both of which described
a reduction in spending on cancer research).
Responses to the direct attitudinal question
When asked directly whether, if they were to hear that the
government had reduced its spending on cancer research,
that would make them more or less likely to donate to a
cancer research charity (or to donate more or less than they
already do), the majority of respondents (70.8%) claimed
that government spending decisions make no difference to
their decision about whether or not (or how much) to do-
nate to a cancer research charity. Of the remainder, most
claimed that it would make them more likely to donate,
whereas only eight respondents (2.0%) claimed that it
would make them less likely to donate. Table 5 provides a
cross-tabulation of respondents’ answers to this question
and their answers to the question regarding scenario 4
when they were asked if they would change the level of
their personal out-of-pocket donations to cancer research
charities when faced with a situation whereby the govern-
ment had reduced its spending on cancer research by £100
million (the wording of this scenario most closely matches
the wording of the direct attitudinal question). Note that
Table 5 refers only to the 274 respondents who had given
money to cancer research charities in the previous year.















Coefficient Std. Err. Coefficient Std. Err. Coefficient Std. Err. Coefficient Std. Err.
Constant 47.39 *** 4.54 50.94 *** 6.76 43.87 *** 6.21 43.38 *** 4.70
Treatment effects (dummy variables)
Scenario 2 4.59 *** 0.78 5.05 *** 1.09 4.14 *** 1.12 4.59 *** 0.78
Scenario 3 9.55 *** 0.78 10.47 *** 1.09 8.64 *** 1.12 9.54 *** 0.78
Scenario 4 8.75 *** 0.78 9.86 *** 1.09 7.66 *** 1.12 8.75 *** 0.78
Scenario 5 2.87 *** 0.78 2.94 *** 1.09 2.79 ** 1.12 2.87 *** 0.78
Personal experience of cancer (YES = 1) 5.69 ** 2.81 4.71 4.29 6.29 * 3.74 5.53 ** 2.82
Personal donation to Cancer Research UK
in the last year (YES = 1)
10.38 *** 2.57 9.37 ** 3.75 11.28 *** 3.56 10.34 *** 2.57
Personal donation (any type) in the last
year (YES = 1)
−7.58 * 4.11 −12.28 ** 5.77 −1.81 5.89 −7.42 * 4.11
Guess of percentage of government spending
on medical research that is on cancer research
9.95 6.33 17.27 * 9.06 0.64 8.91 9.94 6.32
Order in which scenarios were presented
(12345 = 0; 12534 = 1)
Not included Not included Not included 2.06 2.46
Number of observations (panel data) 2005 990 1015 2005
Number of respondents 401 198 203 401
Likelihood-ratio test – χ2 219.85 *** 136.10 *** 92.10 *** 220.55 ***
Significant to the: ***=1% level; **=5% level; *=10% level.
aFurther details of the regression and the results of other variables tested are available on request.
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Qualitative data – comments made by respondents
All respondents were invited to leave comments about
their answers to scenario questions, 78 of whom (19.5%)
opted to do so. The comments were then coded and orga-
nised into categories. The most common category of com-
ment (made by 12 respondents) referred to the notion
that the respondent’s personal donations would not be
affected by changes in government policy (for example, “I
would still pay the same amount regardless of how much
the government funds as it is private to me how I want to
spend money”). Other common categories of comment in-
cluded surprise/disgust at actual government funding
levels and explanations by respondents that they tend to
give money to research focused on disease areas that they
are connected to in some way (both made by nine respon-
dents each).
Respondents who had not earlier claimed to have given
money to cancer research charities in the previous year
were asked what might encourage them to do so; 72 of
the 127 respondents who were asked this question (56.7%)
left a comment of some sort. Again, the comments were
coded and organised into categories. The most common
factors suggested were personal experience of cancer
(mentioned by 15 respondents, predominantly those in
the higher) and having a larger disposable income (men-
tioned by 13 respondents, predominantly those in the
lower socioeconomic grades). None of the respondents
who were asked this question gave a response that men-
tioned the level of government funding for cancer (or any
other type of) research.
Discussion
This study has elicited the views of a sample of the United
Kingdom general public about how (hypothetical) changes
in government spending on cancer research might affect
their own willingness to donate to cancer research char-
ities, and to hypothecate some of their income tax to
them. We found that most people’s tax hypothecation and
private donation decisions to cancer research charities
were only slightly affected by information about govern-
ment spending on cancer research. When respondents
were asked to suppose that the government had cut
funding for cancer research, the overall tendency was to
give a slightly larger share to cancer research charities of
the £100 of their income tax that they were told they may
allocate. When respondents were asked to suppose that
the government had increased funding for cancer re-
search, the overall tendency was to give a slightly smaller
share to the allocation to cancer research charities. The
impact of an increase in government funding was smaller
in magnitude than that of a cut. Notwithstanding these
overall tendencies, most respondents’ preferred allocation
splits did not vary much from scenario to scenario, and a
sizeable minority (38.2%) of respondents chose the same
allocation split in all five scenarios, i.e. regardless of gov-
ernment spending on cancer and other medical research.
In all five scenarios, the vast majority (88.2–92.2%)
of respondents said that they would not take the op-
portunity to change the levels of their existing personal
out-of-pocket donations to cancer research and/or other
medical research charities, despite the fact that these
charities would be receiving additional funding by way
of the £100 allocation of the respondent’s income tax.
For those respondents who said that they would change
their personal donations, the larger their preferred allo-
cation to cancer research charities, the more likely they
were to increase their personal donations to cancer re-
search charities.
Our finding that most people’s private donation deci-
sions to medical research charities are only slightly af-
fected by information about government spending on
medical research is further supported by the responses to
the direct attitudinal question. Approximately two-thirds
of respondents claimed that hearing that the government
had reduced its spending on cancer research would not
affect their decision about whether to donate to a cancer
research charity, or the size of their donation.
The open-ended comments made by respondents paint
a similar picture. Few of the comments mentioned gov-
ernment funding for medical research as a factor affecting
their decisions, with respondents claiming that personal
experience of cancer, or increases in their disposable in-
come, would be the main drivers behind any future deci-
sion to donate to a cancer research charity. Of the










Question regarding scenario 4 (impact on out-of-pocket
donations)
Would reduce 0 2 4 6
Would not
change
6 171 65 242
Would increase 1 8 17 26
Total 7 181 86 274
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respondents who left a comment about their answers to
the scenario questions, 15.4% took the opportunity to
reiterate the fact their personal donations would not be
affected by changes in government policy or funding
levels. Nevertheless, there were some respondents whose
preferred allocations varied substantially from scenario to
scenario. Overall, the results suggest that crowding out
effects outweigh any possible crowding in or signalling
effects. Of the respondents who amended their allocation
splits upon being given new information about govern-
ment spending levels, the majority tended to move in the
opposite direction to the government – increasing the
share for cancer research charities when government
funding for cancer research was cut, and reducing the
share for cancer research charities when government
funding for cancer research was increased.
On average, when moving from scenario 2 (realistic esti-
mates of government spending) to scenario 4 (£100 million
cut in government funding for cancer research with no in-
crease in government funding for other medical research),
respondents increased the share of the £100 of income tax
allocated to cancer research by £4.16. Given that the adult
population of the United Kingdom is approximately 50
million [29] and assuming that the wider population would
behave in accordance with the stated preferences elicited
in this study, then, if the government were to cut funding
for cancer research by £100 million and gave each indi-
vidual £100 of income tax to allocate to cancer research
or other medical research charities of their choosing,
then cancer research charities could, between them, re-
ceive £208 million from such a policy. In other words,
the general public may rebalance tax spending back to
cancer research, given the chance, if the government were
to cut its planned spending on cancer research and to
introduce a mechanism for redistributing income tax to
medical research charities. The direction of intent is clear.
However, not much can be read into the magnitude of the
additional allocation to cancer research owing to the
hypothetical nature of the exercise and the likelihood that
the magnitude will be strongly affected by the size of the
amount that the individual is given the discretion to allo-
cate. In the United Kingdom, it is not currently possible to
reallocate tax income in this way.
In addition, since the mean change in personal out-of-
pocket donation to cancer research charities is greater in
scenario 4 than in scenario 2, cancer research charities
might also expect to receive a small amount of further do-
nations from the pockets of individuals who already give
money to these types of organisations, should the govern-
ment cut its spending on cancer research. Comparing sce-
nario 4 with scenario 2, the additional £0.39 per person
saying they already donate to cancer research charities,
who make up 68.3% of our survey respondents (274/401),
suggests that, if replicated across 68.3% of the 50 million
United Kingdom adult population, this would amount to
extra out-of-pocket donations of £13 million. This would
not go far towards offsetting the hypothetical £100 million
cut in government spending on cancer research.
However, we would urge caution when scaling up in this
way: in reality, even the better-informed members of the
public would be unlikely to have access to information
about government spending levels as presented in the sce-
narios. Furthermore, means tend to be skewed by extreme
values (such as respondents who claim that they would
give an additional £100 to cancer research charities after
already having been given the opportunity to allocate £100
of income tax to those charities) that may not accurately
reflect what would happen if the scenario were actually to
occur. It is perhaps more telling that the median change
in personal out-of-pocket donations to both cancer re-
search and other medical research charities was zero in all
five scenarios.
It is not surprising that the respondents were largely un-
informed about current levels of government spending on
medical research. A survey of public views about science
and biomedical research reported that, when asked which
groups they were aware of that carry out medical research
in the United Kingdom, only 6% mentioned the govern-
ment, 18% mentioned the National Health Service, 23%
mentioned universities, 48% mentioned medical research
charities, and 16% said that they did not know [30].
Most respondents guessed that government spending
on medical research is far more concentrated on cancer
research than is actually the case. This may explain the
large shares of the allocations given to cancer research at
the expense of other medical research (in each of the sce-
narios, the mean amount given to cancer research char-
ities was greater than £50 of the £100 to be allocated).
However, the fact that cancer research was clearly the
main subject of the survey, and the fact that respondents
were informed that the study was funded by Cancer
Research UK, is likely to have resulted in a focusing effect
whereby respondents placed more importance on cancer
than they otherwise might have done. In terms of the pur-
pose of this study, however, the actual amounts given to
cancer research charities in any given scenario are less im-
portant than the ways in which those amounts change
from scenario to scenario.
After having been given the opportunity to allocate £100
of income tax to medical research charities of their choos-
ing, very few respondents then said that they would take
the opportunity to reduce the size of their existing per-
sonal out-of-pocket donations. Most existing donors to
medical research charities said that they would not change
the size of their personal donations. This is particularly
the case in scenario 1, in which respondents were not
given any information about government funding levels.
This means that their answers regarding personal donations
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under scenario 1 would not have been driven by concerns
that the government is spending too little (or too much) on
medical research.
However, a drawback of stated preference studies is that
they only elicit data on what respondents say that they
would do/prefer – we do not know whether they would
behave in the same way if the hypothetical scenarios were
actually to happen. Survey respondents may exaggerate
claims about their positive behaviour (i.e. giving to charity)
either to appease or impress the researcher, or because
they have a deluded view of themselves. Future research
could combine the stated preference design with an ex-
perimental lab-based study in order to test whether people
act on their claims when given real money to allocate.
Another limitation of such studies, particularly those
administered over the Internet without an interviewer on
hand to provide guidance, is that it is difficult to know
whether respondents paid sufficient attention to the tasks
and took the scenarios seriously. We therefore excluded re-
spondents who completed the survey implausibly quickly
(in less than 3.5 minutes). We also tested the impact of ap-
plying alternative (stricter) cut-offs; these did not affect our
general findings.
A further issue is the potential for experimenter demand
bias, whereby respondents give responses that they believe
the researchers are expecting. However, given the compet-
ing theories of crowding out and crowding in, we had no
a priori expectations about the direction of impact of pro-
viding information about cuts to or increases in govern-
ment funding levels. Furthermore, even if the study design
had led respondents to infer that they were expected to
change their allocations and out-of-pocket donations in
response to changes in the information provided, we still
observe few instances of respondents doing so.
Conclusions
The results of our stated preference survey of 401 adults
in the United Kingdom lead to the overall conclusion that
the public’s decisions about how much to donate to can-
cer research or other medical research charities are not
greatly affected by changes to government plans about the
amount of public funding of cancer or other medical re-
search. Personal experience of cancer appears to be a
more important driver of people’s decisions to donate to
cancer research charities.
Endnote
a Though a large proportion of this funding is provided
by charities that do not fundraise from the general
public.
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